In May 2022, The US FDA authorized the use of RADICAVA ORS (edaravone) in an oral formulation for the treatment of ALS.

The first healthy volunteers have been dosed in an early clinical trial testing NRG5051, a disease-modifying therapy for ALS ...

Aperture Therapeutics is advancing APRTX-003, an RNA-based antisense therapy targeting MMP9, as a potential ALS treatment.

The FDA has granted fast track designation to a vectorized antibody that targets RNA-binding proteins characteristic of neurodegenerative diseases.According to a press release from VectorY ...

Patients with a rare form of ALS may finally have hope for a promising new treatment. Judge disqualifies US attorney in New York, tosses Letitia James subpoenas Trump’s controversial ballroom could ...

Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production ...

PORTLAND, Ore., Dec. 30, 2025 /PRNewswire/ -- ALS Northwest increased its financial investment in ALS research throughout 2025, accelerating new approaches in ALS treatment, prevention, and ...

CHICAGO, Dec. 30, 2025 /PRNewswire/ -- ALS United Greater Chicago increased its financial investment in ALS research throughout 2025, accelerating new approaches in ALS treatment, prevention, and ...

Video provided by WCVB. Rocheleau writes about his experiences with ALS: https://www.timesunion.com/opinion/article/hearst-editor-matt-rocheleau-als-mnd-gehrig-21227170.php Jaclyn Reiss, wife of ...

Early initiation of tofersen (Qalsody) was associated with a numerically slower decline in people with SOD1 amyotrophic lateral sclerosis (ALS) compared with delayed treatment, according to data from ...

My Dad Was Gay — But Married To My Mom For 64 Years. As She Died, I Overheard Something I Can't Forget. Walz responds to surprise ICE operation Long-delayed inflation data will finally be released ...

Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production, a process that fails in amyotrophic lateral sclerosis (ALS).